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Abstract
Background: Producing high-quality, relevant systematic reviews and keeping them up to date is challenging. Cochrane
is a leading provider of systematic reviews in health. For Cochrane to continue to contribute to improvements in heath,
Cochrane Reviews must be rigorous, reliable and up to date. We aimed to explore existing models of Cochrane Review
production and emerging opportunities to improve the efficiency and sustainability of these processes.
Methods: To inform discussions about how to best achieve this, we conducted 26 interviews and an online survey with
106 respondents.
Results: Respondents highlighted the importance and challenge of creating reliable, timely systematic reviews. They
described the challenges and opportunities presented by current production models, and they shared what they are
doing to improve review production.
They particularly highlighted significant challenges with increasing complexity of review methods; difficulty keeping
authors on board and on track; and the length of time required to complete the process. Strong themes emerged about
the roles of authors and Review Groups, the central actors in the review production process.
The results suggest that improvements to Cochrane’s systematic review production models could come from improving
clarity of roles and expectations, ensuring continuity and consistency of input, enabling active management of the review
process, centralising some review production steps; breaking reviews into smaller “chunks”, and improving approaches to
building capacity of and sharing information between authors and Review Groups.
Respondents noted the important role new technologies have to play in enabling these improvements.
Conclusions: The findings of this study will inform the development of new Cochrane Review production models and
may provide valuable data for other systematic review producers as they consider how best to produce rigorous, reliable,
up-to-date reviews.
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Background
Systematic reviews gather and synthesise the best evidence
from research to support informed healthcare decisions
by patients, health professionals and policy-makers. As
such, systematic reviews are a vital step in the translation
of the results of research into practice and policy to im-
prove healthcare outcomes [1, 2].
Producing high-quality, relevant systematic reviews
and keeping them up to date are challenging [3, 4]. The
increasing methodological complexity of the review
process and the rapidly expanding body of evidence
available for review add to the difficulty—and the impact
of both factors is only likely to increase in the future [3].
Cochrane is a leading provider of systematic reviews in
health. Cochrane Reviews are prepared by review author
teams, working with Cochrane Review Groups. Each
Cochrane Review Group is responsible for a specific area
of health care or policy. The Cochrane Database of Sys-
tematic Reviews now includes more than 6500 system-
atic reviews, with another 2500 reviews currently
underway [5].
Cochrane has been producing systematic reviews for
more than 20 years. In recognition of the changing en-
vironment and potential role of new technologies,
Cochrane is undertaking a range of initiatives to identify
and scale up new ways of working that ensure Cochrane
Reviews continue to be relevant and reliable and that re-
view production is efficient and sustainable.
While a number of studies have been conducted ex-
ploring the quality and impact of Cochrane Reviews [6],
we are not aware of any published research documenting
how reviews are produced within Cochrane and how this
could be improved.
This study explores systematic review production
models currently employed within and beyond Cochrane.
It highlights what people are doing to improve the quality
and timeliness of Cochrane systematic review production;
what is working, what challenges they are facing and what
is needed to enable further improvement.
Methods
We aimed to understand the strengths and weaknesses
of the processes by which systematic reviews are cur-
rently being produced within and beyond Cochrane and
to identify opportunities for improvement to enable effi-
cient and sustainable production of reliable, relevant,
up-to-date Cochrane Reviews.
We used a primarily qualitative approach with some
embedded quantitative methods to explore participants’
experiences with systematic review production models,
including both an online survey and semi-structured
interviews.




Potential interview participants were from two groups:
1. Participants associated with Cochrane Review
production
This group included the following:
– Cochrane Review authors
– Editors and staff of Cochrane Review Groups
(the 52 Review Groups responsible for producing
Cochrane reviews in health-related domains)
– Members of the Cochrane Editorial Unit (the
central Cochrane unit with responsibility for
supporting Cochrane groups to improve the quality
of Cochrane Reviews)
– Members of Cochrane Methods Groups (the 17
Methods Groups responsible for developing and
advising on methods for Cochrane Reviews);
– Staff of Cochrane Centres (Cochrane’s geographical
representatives in more than 43 countries and
regions)
– Members of the Cochrane Central Executive Team
2. Participants associated with non-Cochrane system-
atic review production
This group included professionals working in systematic
review production for systematic review firms, health
technology assessment and clinical practice guideline de-
velopment groups.
Potential participants were invited to participate in an
interview through existing communication channels for
Cochrane including the Cochrane website, newsletters,
email lists, social media and other similar methods. Indi-
viduals known to the investigator team were directly
emailed invitations to participate in the interview and
encouraged to forward the invitation to other potential
participants.
Participation was voluntary. Potential participants
were provided with a participant information statement
by email prior to the interview and provided evidence of
informed consent by return email.
Surveys
Potential survey participants were associated with Cochrane
Review production and included the following:
– Cochrane Review authors
– Editors and staff of Cochrane Review Groups
– Members of the Cochrane Editorial Unit
– Members of Cochrane Methods Groups
– Staff of Cochrane Centres
– Members of the Cochrane Central Executive Team
We planned to recruit 30–50 survey respondents.
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Participants were invited to complete the survey
through existing communication channels for Cochrane
including the Cochrane website, newsletters, email lists
and social media. Individuals identified by the investiga-
tor team were also directly emailed invitations to partici-
pate in the survey and encouraged to forward the
invitation to other potential participants.
Participation was voluntary. Potential participants were
invited to visit the survey webpage which provided a par-
ticipant information statement. Choosing to proceed with
the survey constituted informed consent.
Data collection
Interviews
Data were collected using a semi-structured interview in
person or by phone, Skype or similar technology. The
interview schedule was developed by TT in consultation
with the other authors and pilot-tested before use.
Interview questions were loosely based on a pre-
determined interview schedule, with questions varied so
as to be relevant to the interviewee’s role and experience
and in the light of responses to preceding questions. De-
tailed notes were taken during the interviews. Interview
questions explored the interviewee’s experience of differ-
ent approaches to review production and their reflec-
tions on the benefits and weaknesses of these different
approaches. Interviewees were asked to describe which
characteristics of review production processes contribute
most to high-quality, timely review production; what the
most common challenges are; and where there are op-
portunities to improve the current production model.
Interviews were conducted by TT, a Cochrane Review
author and systematic review methodologist who is fa-
miliar with but has no authoritative role within
Cochrane. TT is an experienced qualitative interviewer.
Survey
Data were collected using an online survey tool. The
survey included demographic questions, 18 close-ended
and 10 open-ended questions. The close-ended ques-
tions asked respondents to rate a set of review produc-
tion characteristics in terms of their importance to
review quality, importance to review timeliness and diffi-
culty to achieve.
The open-ended questions sought information on re-
spondents’ experiences of how the review production
processes to which they had contributed had been orga-
nised. Respondents were asked to reflect on times that
these processes had worked well, leading to production
of high-quality, useful, timely reviews, and describe how
the review production was organised. Similarly, respon-
dents were asked to consider when these processes had
not worked well and identify elements of the process
that may have contributed to the poorer outcomes.
Respondents were prompted to consider characteristics
such as team formation, team management, roles within
teams, managing quality and time expectations, author
team skill mix, structure of and support for review teams
and accountability mechanisms and reflect on what ap-
proaches had been most effective in their experience.
Respondents were also invited to suggest opportunities
to improve the current review production model.
Participants could choose whether to provide their




port/downloads/nvivo10-for-windows) was used to ana-
lyse qualitative data and to extract quotes. Thematic
analysis was undertaken of interview notes and qualita-
tive survey responses. These were initially analysed using
open coding to identify key concepts which were then
collapsed into emerging themes. TT undertook the pri-
mary data analysis. SG and JE reviewed a subset of the
coding and collaborated on the conceptual development
of themes. A draft report of the analysis was provided to
interview respondents and survey respondents who pro-
vided contact information, for feedback.
Qualitative data from interviews were initially analysed
independently of the data from the open-ended ques-
tions in the survey; however, as the similarity of themes
became apparent, the analysis was combined.
Results
Respondents
We conducted 26 interviews between July and November
2015, until data saturation was reached. Interview partici-
pants included Cochrane Managing Editors of Cochrane
Review Groups (6), authors of Cochrane Reviews (6),
Review Group staff (other than Editors) (3), Coordinating
Editors of Cochrane Review Groups (2), Editors (other
than Managing or Coordinating Editors) (2), Cochrane
Consumer contributors (1) and systematic review authors
and guideline developers from outside Cochrane (6). The
interview participants were from seven countries and in-
cluded six participants with a first language other than
English and three participants from low- and middle-
income countries.
One hundred six people provided online survey re-
sponses between August and October 2015. Survey partic-
ipants described themselves as Authors (47), Managing or
Coordinating Editors (29), Information Specialists (13),
Consumers (15), Methodologists (11), Editors (5), Centre
Staff (2), CEU staff (1), and Other (8) (multiple responses
allowed). The respondents had a median of 10 years of
Cochrane experience (range 0.4–20). The survey respon-
dents provided extensive answers to the open-ended
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questions, with 52 respondents (49%) providing at least
one answer to an open-ended question and a total of more
than 14,000 words of free-text responses.
External respondents were very familiar with Cochrane
Review production and had useful insights about aspects
of their own review production approaches that might
translate well into the Cochrane context or could cata-
lyse new ways of producing reviews within Cochrane.
Except where specifically noted below, their responses
were very strongly aligned with those of the respondents
from within Cochrane.
How are Cochrane Reviews produced?
The respondents described the importance and the
challenge of creating high-quality, relevant, up-to-date
Cochrane systematic reviews. Their responses highlighted
that while the methods of Cochrane Review production
are very systematic, the production process is also variable
and creative. It was also clear that there is substantial vari-
ation in the approaches taken to review production both
between, and also within, Cochrane Review Groups. Al-
most every aspect of the review production process varies
to some extent between groups.
Similarly, the respondents noted that while each indi-
vidual review ostensibly follows the same approach, they
are not predictable. Reviews are undertaken in an envir-
onment that is volatile and frequently under-resourced,
and they are undertaken by people with multiple com-
peting commitments and widely varying levels of skill
and availability. Review topics cover the full gamut from
incredibly narrow to courageously broad, and vary, often
unforeseeably, in complexity. Each review presents its
own unexpected challenges.
However, across the respondents strong themes emerged
about the roles of authors and Review Groups, the central
actors in the review production process.
Working effectively with, and within, author teams is critical
and challenging
Cochrane Review authors are at the centre of review
production. The respondents frequently emphasised that
good relationships between the Cochrane Review Group
and the author team, and within author teams, were cru-
cial to good review production processes.
that’s the ‘collaboration’ bit of The Cochrane
Collaboration... it’s all about the human relationships
(Managing Editor)
good people drive good processes (Author, Editor)
Team formation There was a shared sense that while
the make-up of the author team is the key to successful
review production, in most circumstances, processes for
formation of author teams and task allocation within au-
thor teams are informal and organic. This was not per-
ceived to be problematic.
Team formation is organic, ask around, bring
people together, there is no process (Coordinating
Editor, Author)
[We] have tried a prescriptive process, and wouldn’t
recommend it (Managing Editor)
Author requirements Requirements for author teams
vary, with some Review Groups having very stringent re-
quirements and others determined to accept all comers.
However, the respondents agreed on the importance of
having an effective review team leader. There was also
acknowledgement that while requirements for authors
(e.g. having a team member who has previously con-
ducted a Cochrane Review) are often useful, they are not
enough to ensure success.
Some people just get on and do it, and you can’t
predict who will (Managing Editor)
Linked to this, there was also a clear tension (both
within and between Review Groups) between focusing
on capacity building (with benefits being bringing in
new authors and the greater time availability of junior
team members) and the benefits of experienced authors
who require less hands-on support. Review Groups have
strongly held widely varying positions on this.
Abandon inclusiveness regarding new authors
(Author, Editor, Methodologist)
[Our] group will take anybody who wants to do a
review, work with the enthusiasm of people, … let
them do it as long as they do it well (Author,
Coordinating Editor)
Many respondents highlighted the importance and dif-
ficulty of sourcing timely clinical input throughout the
review process and of not wasting this precious resource
on tedious tasks like screening search returns.
Payment and incentives
The respondents described a wide range of payment and
incentive models for author teams. These included fully
paid teams, outsourcing to private companies, teams with
some paid members (often Review Group or a partner or-
ganisation’s staff), stipends for travel to the Review Group
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office or similar and fully volunteer teams. All of these ap-
proaches were perceived to have strengths and weaknesses.
Paid authors Having been funded, protected research
time for the lead author was a frequent suggestion for
improving the timeliness of review production.
Have allocated funding to do the review really
helps – especially for dedicated time of the lead
author (Deputy Coordinating Editor, Author)
At partner organisations Funding staff at partner orga-
nisations to conduct reviews was seen as a good way to
build capacity, particularly when partner organisations
were in low- and middle-income countries (LMICs). How-
ever, the respondents also highlighted weaknesses with
this model, with paid authors likely to end up being re-
sponsible for many reviews, potentially across several Re-
view Groups, and difficulties arising with accountability.
[A downside] is one individual ends up being
responsible for a lot of reviews. If employed for
several years and do 2 to 4 reviews per year, after 5
years they will have 20 reviews to manage, and these
sit across Review Groups, so pressure not just from
[our Review Group], but also from other Review
Groups. (Managing Editor)
I’m not their line manager, and neither is my line
manager, [this is a] con in terms of how we work with
partners. (Managing Editor)
At Review Groups Employing staff at Review Groups to
lead or support reviews was frequently suggested as an
effective model, although respondents questioned the
feasibility of employing fulltime staff in lower resource
settings.
I am a firm believer that Review Groups need to
employ researchers to lead reviews, particularly to
do the donkey work, like data extraction (Consumer,
Author, Editor)
Our best experiences have tended to come with
motivated author teams who have some dedicated
time to carry out the review and have an experienced
author on the team. This works particularly well when
that person is employed at the editorial base and can
facilitate good communication between the authors
and the editorial base. This has tended to produce
the most timely, high quality reviews. (Author,
Consumer, Editor)
In developed world, the model of commissioning,
fulltime researchers; it’s not suitable for LMICs
(Author)
Volunteers The respondents were quick to point out
that while funded or partially funded teams were often
more productive, there were both philosophical and
practical reasons why volunteers should remain at the
heart of Cochrane.
[I would] Hate to see Cochrane only having paid staff,
but as part of the team it is essential (Author, Editor)
The respondents highlighted the key role of volunteer
Cochrane authors, both in producing the bulk of
Cochrane Reviews and in producing a wide variety of re-
views and also in maintaining the connection between
clinicians and community members and the research
that was of interest to them.
Working with, and as, volunteer authors was acknowl-
edged to be very challenging, but incredibly valuable.
With volunteers it is very difficult, but volunteers are
the only way Cochrane can be as productive as it is
(Consumer, Author, Editor)
The respondents highlighted the increasing difficulty
of finding volunteers with available, flexible time to work
on Cochrane Reviews, both in LMICs and in high-
resource settings as the funding model changes.
It’s hard to see how a completely voluntary model is
sustainable at scale in those [LMIC] settings. (Author,
Coordinating Editor)
Commercial systematic review producers A small
number of Review Groups described their experiences of
contracting commercial systematic review producers for
some or all of the review process. While obviously
dependent on availability of funding, these arrangements
were seen to be very efficient at producing high-quality
reviews quickly.
Companies are far more efficient than universities,
lower overheads, more nimble (Coordinating Editor,
Author)
Incentives and fellowships Small incentives and fel-
lowships were felt to be useful in providing legitim-
acy for review work for both Review Groups and
authors, facilitating project management by Review
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Groups and allowing authors to demonstrate the
value of review work to their institutions. Fellowships
for authors to visit Review Groups were particularly
valued for the opportunity they provided to work
face to face.
… we have had some success with monetary
incentives … that come with non-negotiable publication
deadlines. This allows the editorial base to legitimately
… set deadlines with the review team, as well as
providing the opportunity of offering peer referees
a small incentive in return for prompt feedback.
(Managing Editor)
A previous round of work with that same Cochrane
group had been given minimal funding for some
updates ... This in no way covered the costs of the
work, but it helped to oil the wheels in some
universities and allowed one of us to attend a
Cochrane symposium. (Author)
Ability to work face-to-face is invaluable (Managing
Editor)
There was widespread acceptance that having some
funding makes author teams more likely to successfully
complete their review, largely by leading to a greater
sense of accountability. However, this was paralleled by
acknowledgement that funding does not solve all review
production problems.
Things move along in a different way where there is a
little funding for the review team to justify spending
the time (Managing Editor)
The role of Review Groups varies widely and can be unclear
Project management
Project management of review production processes
emerged as a substantive issue. The extent of project
management undertaken by Review Groups varies
widely with some groups providing active, hands-on
management by one of the following: the Managing
Editor, a paid lead reviewer (often a member of the Re-
view Group staff ) or unpaid guarantor authors. Usually,
Review Groups provide this level of active project man-
agement for a small selection of priority reviews; how-
ever, some aim to cover all reviews. Other Review
Groups describe themselves as “hands-off” and do not
provide any project management of review production.
There is a sense of an overall trend towards more
hands-on management, although this is acknowledged
to be very resource intensive and sometimes perceived
to be unattainable.
If you can find a Review Group where people are less
hands-on than we are and are producing good reviews,
I’d like to see it (Coordinating Editor, Author)
The role of Review Groups
There is also considerable variation in how Review
Groups perceive their wider role in the review produc-
tion process. This leads to substantial differences in the
extent to which Review Groups see their role as provid-
ing clinical input, methodological guidance, editorial
oversight and/or author support.
Conflation of review publication and review production
A related theme was the conflation of review production
and review publishing roles. The respondents were very
concerned about the challenges this conflation creates in
the production process (see, for example, discussion of
peer review below). They also highlighted that this leads
to, at the very least, a perceived conflict of interest for
Review Groups, which are responsible for both produ-
cing the review and making the decision about when a
review can be published. There was a perception of a
potential for there to be perverse incentives for Review
Groups to publish reviews that were not of the highest
possible quality.
[The] production process is currently confused with
publication process (Author)
Peer review
Substantial issues with peer review processes were men-
tioned by many respondents, both authors and individ-
uals within Review Groups. These issues include the
long time delays introduced by peer review processes;
lack of clarity of the purpose of peer review; difficulty
sourcing appropriate, high-quality peer review; and chal-
lenges with collating and communicating the feedback
in a constructive, helpful way for authors.
Best peer review is from editors. External peer review
is cosmetic. (Coordinating Editor, Author)
Peer refereeing process timeframes are terrible. Can
be months before feedback is received, then authors
respond, then another round of feedback. Can be 6-12
months, which is very demotivating. (Author, Editor)
What is needed in a new approach?
Most respondents from within Cochrane were either ac-
tively looking for or actively trialling new approaches to
review production.
The ongoing and ubiquitous search for new approaches
highlights that there is shared understanding that solu-
tions are urgently needed to the challenges that review
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production face and also that there is strong motivation to
find effective ways to improve review production.
While the approaches to improvement being explored
by the respondents differed, most seem designed to ad-
dress a similar set of issues.
Improved clarity of roles and expectations
Many of the challenges with current review production
processes raised by the respondents appeared to be due
to underlying lack of clarity about the roles and respon-
sibilities of different contributors to the review process,
particularly authors and Review Groups, and to a lesser
extent Methods Groups.
The respondents described challenges arising from a
lack of clarity of expectations about the following:
 Review quality, in terms of both methodological
standards and standard of writing
 Timelines in terms of turnaround of review stages
by both authors and Review Groups
 Roles of author teams and Review Groups in the
review production process
There is a big difference in expectations of authors.
Some don’t communicate with the Review Group at
all. Some think that we are going to write it for them.
(Deputy Coordinating Editor, Author)
A clear team leader is key. Also clarity of roles at
outset. (Author, Managing Editor)
There was a feeling that one reason for poor review
timeliness was a lack of clear understanding on the part
of authors of the true investment of time and effort re-
quired to complete a review.
Ensuring commitment on the part of the author team
to complete the review was an important goal for Review
Groups, though it was not clear how this could be
achieved. Some Review Groups raised both the appeal of
and their hesitancy to implement formal, signed agree-
ments with author teams that explicitly set out expecta-
tions, roles and responsibilities for authors. One of the
reasons for hesitancy was a recognition of their own in-
ability to feasibly respond within agreed timelines.
If we could guarantee timely feedback [as a Review
Group] then maybe we could expect timely input
from authors too (Author, Editor)
Several respondents emphasised the importance of
getting off to a good start: the value of investing time to
ensure clarity at the beginning of a review process in
order to avoid later issues with the review. Approaches
to improving clarity and commitment in the early stages
of the review production process included increasing the
rigour of title registration processes, extending protocol
processes and raising author team requirements to en-
sure that reviews start well and avoid pitfalls later in the
process.
The perception is that publishing the protocol is
straightforward, it’s not, and it’s an important starting
point for the review. Being proactive at this stage is
helpful (Deputy Coordinating Editor, Author)
The start has it all. (Author)
[Our approach is] Massive frontloading of input,
review proposals and protocols. [We are] Thinking
about asking for Summary of Findings tables at
protocol stage (Managing Editor, Author)
The respondents also noted that there was an expect-
ation that reviews would use increasingly complex
methods. They highlighted that this increased complexity
led to increased workload and timelines for both authors
and Review Groups and suggested that there should be a
renewed focus on simple, reliable, useful reviews.
Go back to basics… Stop expecting complexity in all
reviews (Author)
Increased continuity and consistency of input
The respondents highlighted the vital importance of enab-
ling continuity and consistency of input throughout the
review process. They wanted consistent clinical, methodo-
logical and editorial input from all contributors to the re-
view, including the author team, Review Group,
methodologists and editors (including copyedit),
throughout the review lifecycle, and they were frus-
trated when they received conflicting advice, which
often led to delays or rework. This idea was linked to
the importance of having an effective author team
leader, discussed further below.
Most important is that [a] project manager is across
the whole process so it has continuity (Author,
External Review Producer)
Consistency throughout the review production and update
process
Authors particularly valued consistency of input in order
to ensure that earlier decisions are not revisited—for ex-
ample, that methods signed off at the protocol stage are
not queried at review submission. Linked to this, some
respondents suggested that systems that would allow
staged quality assurance sign off at appropriate points
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within review production, rather than one final quality
assurance review, would be beneficial in terms of quality
and timeliness of reviews and author motivation.
The respondents suggested that it might be useful to
extend the idea of the author team beyond a single re-
view and beyond a single version of a review, to encom-
pass a community that was responsible for the ongoing
life of a review as a way of ensuring ongoing consistency
and continuity of input.
We need to reduce dependence on a single author
team to see a review from outset through years of
updates. Teams should become much more dynamic;
if someone has to drop out of a task, then there
should be someone else who can take their place.
Reviews should be owned explicitly by groups rather
than authors. There should be author membership
communities formed around topics or CRGs.
(Coordinating Editor, Author)
Consistency across reviews
The benefits of ensuring consistency of review structure
and content between reviews (and ideally between Re-
view Groups) were also emphasised by the respondents.
Many different approaches to ensuring this consistency
were described, such as standardised methods sections,
use of review and protocol templates, exemplar proto-
cols/reviews, and development of suites of reviews with
shared background, PICO elements, and methods sec-
tions. In some Review Groups, these approaches are
standard practice, and in others, they are quite new and
still controversial. These approaches were all felt to im-
prove both the quality and the timeliness of review pro-
duction, while reducing author workload.
The quality of review improved if authors were given
highly structured protocol and review templates. Also,
interim editorial checks on risk of bias tables and SoF
[Summary of Findings] tables improved quality.
(Coordinating Editor, Author, Methodologist)
Consistency across Review Groups
The author respondents often suggested that standardis-
ing approaches to review production within and between
Review Groups would be an immensely valuable step
forward. Authors often struggled with the differing ex-
pectations and roles of different Review Groups in the
production process.
Technology to support consistency
The respondents noted the value of technology in sup-
porting consistency in a variety of ways including creating,
storing and making available reusable review content; en-
abling linking between related reviews; providing methods
of crosschecking content within reviews to ensure internal
consistency; and providing an audit trail that captures de-
cisions that are made during the review production
process.
If reviewing process can be made easier [by software
and standardisation], people can focus on the bits that
need thinking (Author)
Active, explicit facilitation and management of the review
process
Many respondents noted that a major predictor of high-
quality timely review production is coordination of the
review process by a responsible, experienced person who
is explicitly tasked with overall project management of
the review production process and is appropriately posi-
tioned and skilled to overcome any process hurdles. As
well as providing (or enabling access to) methodological
and content leadership, a key role for this person is to
provide a clear channel of communication with the Re-
view Group.
Some respondents suggested that this role should be
taken by a lead author; others felt it was better per-
formed by a member of staff of the Review Group, often
a research fellow or research associate.
The respondents also highlighted that author support
tools that are designed to support review authoring and
which allow coordination of the work of multiple inde-
pendent contributors have additional, substantial pro-
ject management benefits in enabling oversight of
progress.
Most author teams do not have a senior person to
oversee and manage – technology could provide this
(Author, External Review Producer)
One reviewer needs to lead (or project manage) the
entire review and consult regularly with others, set
deadlines and deliverables. That person needs to be
the conduit for the editorial team and manage review
submissions and revisions. Communication with the
review team is essential. (Author)
Centralisation of some review steps
The current model of review production within Cochrane
devolves responsibility for much of the review production
process to the 52 Review Groups which are each respon-
sible for reviews in particular health-related topic areas.
The potential for centralisation of several aspects of re-
view production to improve quality and timeliness of re-
views was mentioned by a number of the respondents.
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Study identification
This included centralisation of elements of searching for
studies and other Information Specialist activity. The re-
spondents linked this both to the need for increased spe-
cificity of searches (which was seen to be vital for
improved timeliness of individual reviews) and the im-
portance of development of registers of clinical trials to
support review production more broadly. Automation
and machine learning was seen as a key component of
achieving increased specificity of searches.
Trials register[s] and central search is invaluable to
Review Groups and authors (Managing Editor)
[There are ] Huge opportunities in technology…
Particularly automation of early phase of reviews
(Coordinating Editor, Author, Methodologist)
Methods support
There was a strong desire for Cochrane to provide a
central source of methods support. Statistical methods
were mentioned most frequently by both authors and
Review Groups, with Review Groups highlighting that
they often felt unable to access the guidance they needed
to confidently advise their authors. Several respondents
suggested that some form of central statistical support
would be very valuable. Other respondents noted that for
methods that were common for most reviews but that
were “developed and owned” outside of Cochrane (e.g.
GRADE, www.gradeworkinggroup.org), there needed to
be an internal, central source of guidance for how these
tools should be applied to Cochrane Reviews.
[T]here is an opportunity for increased central
oversight of key methods (Deputy Coordinating
Editor, Author)
We don’t have anyone we can ask methodological
questions of (Deputy Coordinating Editor, Author)
Peer review
There was also suggestion of the potential for (at least
partial) centralisation of peer review processes. However,
the respondents felt that for this to be effective, there
needed to be clarity about the purpose of peer review—
whether it is intended to address some or all of meth-
odological, editorial or clinical issues—and for the con-
tinuity of input mentioned above to be ensured.
Flexibility in breaking reviews into smaller, skill-specific
“chunks”
A number of the respondents introduced the idea that it
would be useful to break review production into bite-
size, manageable, skill-specific tasks that could be taken
on by appropriately skilled people.
Some Review Groups already do this by, for example,
giving author teams the option of having some tasks
(e.g. summary of findings tables) completed by Review
Group-based specialists.
Chunking of review tasks was seen as a useful approach
to explicitly ensure there was a good match between the
skills and effort required for the task and the skills and
time availability of the person completing the task.
Chunking was also seen as a useful response to the in-
creasing complexity of methods and as a way of focusing
the limited time of clinical authors on the areas of the
review where their input was most valuable.
The respondents described the value of technology in
enabling chunking by presenting a systematic review as
a series of linked tasks, in holding and synthesising data
from multiple contributors and in providing an audit
trail for review decisions and processes.
Very important to move on from thinking that
everybody has to do every part of the review (Author,
External Review Producer)
Chunking of the review processes into smaller, discrete
pieces of work was also felt to enable clearer communica-
tion and understanding of the effort likely to be required
in each phase of the review process. As mentioned above,
lack of understanding of effort required to complete a re-
view was perceived to be a major reason for drop-out of
authors. Chunking was also felt to build author motivation
by giving authors a sense of progress and achievement
throughout the review process, rather than only acknow-
ledging this at the final submission.
Later in review process [I create] a plan for
completion that chunks the tasks into pieces that
people can understand … Try to give them a sense of
the measurable tasks (Review Group Staff, Author)
Some respondents also linked chunking of review
tasks to an increased ability to involve authors and
others who have a first language other than English in
review production.
Could come to a situation where people do a review,
or tasks, in their own language and translate at the
end (Author, External Review Producer)
Improved approaches to building capacity and sharing
information
Capacity building
The respondents noted that there was a need not only
for upskilling of authors and editors, particularly in new
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review methods, but also in other aspects of the produc-
tion process, including communication and peer review.
Review Groups were seen to be under-resourced, or ill-
equipped, to deliver the kind of training and support
needed to upskill authors in these complex areas.
It is often left to editorial bases (and MEs in
particular) to ensure that Cochrane developments
(e.g. RevMan updates; RoB/SoF/GRADE) are
implemented by review teams and incorporated into
current and future reviews; it would be nice to think
that support for us is considered in any future models.
(Managing Editor)
Information sharing
Several respondents noted that there would be benefits
from improving coordination and communication of Re-
view Group activity focusing on improving review pro-
duction. Highlighting this, a number of respondents
from Review Groups noted that they were undertaking
pilot activities designed to improve review production,
and they were often unaware that other groups were
undertaking similar initiatives.
[I am] not clear how Review Groups are sharing
materials about review production management.
[Our Review Group] has materials, many Review
Groups have these, how can we better share these, so
that we are not duplicating effort on both technical
and management information? (Coordinating Editor,
Author)
Discussion and conclusions
Cochrane is a leader in production of systematic reviews
of healthcare interventions. Ensuring that Cochrane Re-
views continue to meet high standards of quality in an
environment with increasingly complex, extended and
varying methods are a substantial challenge. Diverse data
sources and geographically dispersed author teams add
to this challenge and bring important new opportunities
to improve the reliability, timeliness and usefulness of
Cochrane Reviews.
The participants in this study agreed that there are im-
portant, achievable opportunities to improve the produc-
tion of Cochrane Reviews. These include opportunities
to the following:
 Clarify roles and expectations of authors and
Cochrane Review Groups
 Ensure continuity and consistency of input into reviews
 Actively coordinate the review process
 Centralise some aspects of review production
 Break reviews into smaller ‘chunks’
 Improve approaches to capacity building and
information sharing around review production
This information is being used in discussion with
the Cochrane community to identify and develop
new review production models than can be explored
and piloted. We are currently piloting an approach
to produce living systematic reviews [7], supported
by machine learning and citizen science approaches,
and are exploring pilots focusing on supporting lar-
ger author teams and novel approaches to support
participation in review production by authors in low-
resource settings. Consideration of these approaches
is happening against a backdrop of broader, substan-
tive structural change within Cochrane, particularly
for Cochrane Groups, arising from the structure and
function review [8].
The study was limited to the data provided by the 26 in-
terviewees and 106 survey respondents, and this of course
only captures a small amount of the variety within an or-
ganisation as broad and varied as Cochrane. However, the
extent to which shared themes emerged, and the diversity
of roles, locations, experience and background of the re-
spondents, gives us some confidence in the results. By its
nature, the study had a relatively narrow focus on system-
atic review production within Cochrane; however, the re-
sults may also be useful to other systematic review
producers and particularly those who are interested in ex-
ploring whether and how new technologies such as ma-
chine learning and online collaborative platforms can
support efficient review production.
The findings highlight the ways in which these
and other new technologies offer the potential to
support and coordinate review production by broad-
ening participation, breaking review activity into
smaller skill-based chunks and allowing greater
insight into and more active management of teams
producing reviews.
The effectiveness and ramifications of these new
technological tools, as well as the potential process
changes, need to be further investigated, and their impli-
cations for authors, editors, evidence users and the re-
view publication process need to be understood before
their use can become widespread.
Well implemented, these opportunities could markedly
improve the ability of systematic reviewers, such as
Cochrane, to efficiently and sustainably produce high-
quality, reliable systematic reviews that can support the
translation of the results of research into practice and,
ultimately, improve healthcare outcomes.
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